The Cancer Epitope Database and Analysis Resource (CEDAR)

Zeynep Kosaloglu-Yalcin*, Nina Blazeska, Randi Vita, Hannah Carter, Morten Nielsen, Stephen Schoenberger, Alessandro Sette, Bjoern Peters

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

184 Downloads (Orbit)

Abstract

We established The Cancer Epitope Database and Analysis Resource (CEDAR) to catalog all epitope data in the context of cancer. The specific molecular targets of adaptive T cell and B cell immune responses are referred to as epitopes. Epitopes derived from cancer antigens are of high relevance as they are recognized by anti-cancer immune cells. Detailed knowledge of the molecular characteristic of cancer epitopes and associated metadata is relevant to understanding and planning prophylactic and therapeutic applications and accurately characterizing naturally occurring immune responses and cancer immunopathology. CEDAR provides a freely accessible, comprehensive collection of cancer epitope and receptor data curated from the literature and serves as a companion site to the Immune Epitope Database (IEDB), which is focused on infectious, autoimmune, and allergic diseases. CEDAR is freely accessible at https://cedar.iedb.org/.

Original languageEnglish
Article numbergkac902
JournalNucleic Acids Research
Volume51
Issue numberD1
Pages (from-to)D845–D852
ISSN0305-1048
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'The Cancer Epitope Database and Analysis Resource (CEDAR)'. Together they form a unique fingerprint.

Cite this